31
Germany’s experiences in tackling NCDs in the context of an aging population Prof. Dr. Steffen Flessa Department of Health Care Management University of Greifswald

Germanys experience version 2[1]

  • Upload
    gizhsp2

  • View
    389

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Germanys experience version 2[1]

Germany’s experiences in tackling NCDs in the context

of an aging population

Prof. Dr. Steffen Flessa Department of Health Care Management

University of Greifswald

Page 2: Germanys experience version 2[1]

Contents

1. Demography and Health 2. Strategies 3. Conclusion

Page 3: Germanys experience version 2[1]

1. Demography and Health 1.1 Aging: concept

• Aging: Aging is a multidimensional process of physical, psychological, and social change over time.

aging is not only a question of age – but it has a lot to do with it!

Germany: one of the

oldest populations

in the world!

Page 4: Germanys experience version 2[1]

Demographic Transition

Rate

Phase II Phase III Phase IV Phase

Gross death rate

1 %

Gross brith rate

5 %

Phase V time

Germany: • crude birth rate:

8.8/1000; • crude death rate:

9.2 /1000;

Page 5: Germanys experience version 2[1]
Page 6: Germanys experience version 2[1]
Page 7: Germanys experience version 2[1]
Page 8: Germanys experience version 2[1]

0

2

4

6

8

10

12

14

16

18

20

1950 1960 1970 1980 1990 1998 1999 2000

Life

Birt

h pe

r 100

0

Year

Reason 1: Low Birth Rate

Germany Total Old States New States

Page 9: Germanys experience version 2[1]

Reason 2: medical progress

Women [years]

Men [years]

Life Expectancy [years]

Page 10: Germanys experience version 2[1]

Consequences: NCDs

80 70 60 10 20 50

susceptibility

time [years] … birth

NCD

Page 11: Germanys experience version 2[1]

Epidemiological Transition

0

20

40

60

80

100

0 20 40 60 80 100 120

Incide

nce  an

d  prevalen

ce  [%

]

Time  of  Epidemiological  Transition  [year]

Incidence,  Infectious  diseases Incidence,  NCD

Prevalence,  infectious  diseases Prevalence,  NCD

Page 12: Germanys experience version 2[1]

Causes of Death (Men 2007)

150472;  38%

113405;  29%

30219;  8%

21029;  5%

19067;  5%

56947;  15%

Cardio-­‐Vascular

Cancer

Respiratory

Digestive

Accidents

Other

http://de.wikipedia.org/w/index.php?title=Datei:Todesursachen_01.svg&filetimestamp=20100227122441#file

Page 13: Germanys experience version 2[1]

1.2 Aging: a blessing

• 1514: • 63ys old woman

• 2011 : • 77ys old woman

Page 15: Germanys experience version 2[1]

1.3 Aging: a curse

Page 16: Germanys experience version 2[1]

Health Care Cost and Age

Page 17: Germanys experience version 2[1]

Increase of Demand (Western Pomerania, 2005-2020)

NCD Increase of Demand

Hypertension +6.2%

Diabetes +21.4%

Myocardial infarction +28.3%

Stroke +18.0%

Osteoperosis +19.5%

Dementia +91.1%

Cancer (total +22.6%

Cancer (rectal) +31.0%

Source: Hoffmann 2011

Page 18: Germanys experience version 2[1]

• Direct Cost of Dementia in Germany [€ p.c. p.a.]

Source: Schulenburg et al. 1998; Jönsson/ Berr 2005.

1.4 Example: Dementia

Medical cost

ca. 1.935 €

Non-medical cost

(accommodation, counselling etc.)

ca. 11.685 €

~15%

~85%

Page 19: Germanys experience version 2[1]

• Strongly increasing cost in stages

Source: Schulenburg et al. 1998; Quentin et al. 2009.

Prognosis

Mild (MMSE 20-25)Moderate (MMSE 11-15)

Severe (MMSE <= 10)

02.0004.0006.0008.000

10.00012.00014.00016.00018.00020.000

Schweregrad

Kos

ten

[EU

R]

Cost

p.a

. p.

c. [€]

Severity

Page 20: Germanys experience version 2[1]

2. Strategies

• Overview: – Social Insurance: Long-term Nursing – Training of specialists in geriatrics (doctors, nurses,

etc.) – Homes of the elderly und mobile care – Life-long learning of human workforce – Deferred Retirement – Combat infectious diseases – Individualized Medicine und paradigm shift: Multi-

Cause-Multi-Effect Paradigm – Strengthen Prevention

Page 21: Germanys experience version 2[1]

2.1 Deferred Retirement

0

10

20

30

40

50

60

70

80

90

Zeit 1960 1970 1980 1990 1995 2000 2010 2020 2030 2040

time [year]

popu

latio

n Ge

rman

y [m

illion

]

< 20 years 20-<60 years >59 years

Page 22: Germanys experience version 2[1]

0

10

20

30

40

50

60

70

2000 2010 2020 2030 2040 2050

work

ing

popu

luat

ion

time [year]

20-35 years 36-50 years 51-65 years

Page 23: Germanys experience version 2[1]

0

10

20

30

40

50

60

70

2000 2010 2020 2030 2040 2050

work

ing

popu

luat

ion

time [year]

20-35 years 36-50 years 51-65 years

We must keep our key-agent of production in the process – but this requires investments!

Page 24: Germanys experience version 2[1]

Investments in Health

• Physical – Focus on Prevention – Fostering health promotion

• Mental – Keeping workers creative requires transitional

leadership! • Spiritual

– A sense of meaning, appreciation and contribution! Aging is not simply a medical problem – it requires a new paradigm of leadership!

Page 25: Germanys experience version 2[1]

2.2 Combat infectious diseases

• Old people have more infectious diseases – Sepsis – Pneumonia – …

• “Young” old people have new risks: – HIV and Viagra

Page 26: Germanys experience version 2[1]

2.3 Individualized Medicine und paradigm shift

• Old patients are multi-morbid – >65: average more than 6 drugs, max. 21 – Side-effects: unpredictable

• Treatment depends on many factors: there is no “one-fits-all-medicine” anymore! – Genomics – Proteomics – Metabolomics – …

• A new mind-set: Chronic-degenerative diseases require a multi-cause-multi-effect paradigm of medicine!

Page 27: Germanys experience version 2[1]

2.3 Individualized Medicine und paradigm shift

• Old patients are multi-morbid – >65: average more than 6 drugs, max. 21 – Side-effects: unpredictable

• Treatment depends on many factors: there is no “one-fits-all-medicine” anymore! – Genomics – Proteomics – Metabolomics – …

• A new mind-set: Chronic-degenerative diseases require a multi-cause-multi-effect paradigm of medicine!

• But: very, very expensive! • Do not use the health care system of any other country as blue-print: it is too expensive!

Develop your own cost-effective basic package of treating NCD!

Use your ressources as efficient as possible!

Page 28: Germanys experience version 2[1]

2.4 Strengthen Prevention

0

5

10

15

20

25

30

35

0 20 40 60 80 100 120

Share  of  prevention  bu

dget  in  to

tal  

health  ca

re  bud

get  [%]

Time  of  demographic  transition  [years]

Page 29: Germanys experience version 2[1]

2.4 Strengthen Prevention

0

5

10

15

20

25

30

35

0 20 40 60 80 100 120

Share  of  prevention  bu

dget  in  to

tal  

health  ca

re  bud

get  [%]

Time  of  demographic  transition  [years]

Prevention and Primary Care are not the “Medicine

of the Poor” but a very efficient paradigm for

aging societies!

Page 30: Germanys experience version 2[1]

3. Conclusion

• An aging society will induce a higher share of non-communicable diseases.

• An aging society is a blessing – but it requires wise planning, political commitment, strong leadership, cost-effective interventions.

• Health care financing and social protection are crucial!

Page 31: Germanys experience version 2[1]

Germany is gaining experiences with its aging

population and their NCDs – can we share insights?